LH
Laboratory Corp of America Holdings
Laboratory Corp of America Holdings historical holders
total: 10
Jensen Investment Management Laboratory Corp of America Holdings transactions over time
- Total transactions:
- 31
- New positions:
- 2
- Sold out:
- 1
- Added:
- 18
- Reduced:
- 10
- Held since:
- 2019 Q2
- Held for:
- 28 quarters
- Latest activity:
- 2026 Q1
Eric H. Schoenstein has been an institutional investor in Laboratory Corp of America Holdings (LH) since at least 2013 Q2. According to 2026 Q1 report, Eric H. Schoenstein holds 18,480 shares with a market value of roughly $4.93M representing 0.10% of their equity portfolio. In our earliest available record from 2013 Q2, Jensen Investment Management held about 1.40M shares of LH. Eric H. Schoenstein later completely sold out the position and reinvested in LH again in 2019 Q2. Since at least 2013 Q2, Jensen Investment Management has made 30 more transactions in this position.
Does Eric H. Schoenstein still hold LH?
Yes, Eric H. Schoenstein continues to hold Laboratory Corp of America Holdings (LH). According to their 2026 Q1 report, they maintain a position of 18,480 shares valued at approximately $4.93M, representing 0.10% of their equity portfolio.
Has Eric H. Schoenstein reinvested in LH after selling?
Yes, Eric H. Schoenstein has shown renewed interest in Laboratory Corp of America Holdings (LH). After completely selling their position, they reinitiated an investment in 2019 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $222.12
- Weighted AVG sell price:
- $248.79
LH transactions history by Jensen Investment Management
31 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.10%
|
18,480
|
$266.81
|
$4,930,649
|
-19.02% (-4,340)
|
-0.02%
|
|
2025 Q4
|
0.09%
|
22,820
|
$250.88
|
$5,725,082
|
-9.23% (-2,320)
|
-0.01%
|
|
2025 Q3
|
0.09%
|
25,140
|
$287.06
|
$7,216,688
|
-8.05% (-2,200)
|
-0.01%
|
|
2025 Q2
|
0.08%
|
27,340
|
$262.51
|
$7,177,023
|
-4.14% (-1,180)
|
-0%
|
|
2025 Q1
|
0.07%
|
28,520
|
$232.74
|
$6,637,745
|
-22.06% (-8,070)
|
-0.02%
|
|
2024 Q3
|
0.07%
|
36,590
|
$223.48
|
$8,177,133
|
+2.52% (+900)
|
+0%
|
|
2024 Q2
|
0.06%
|
35,690
|
$203.51
|
$7,263,272
|
+10.50% (+3,390)
|
+0.01%
|
|
2024 Q1
|
0.05%
|
32,300
|
$218.46
|
$7,056,258
|
-1.25% (-410)
|
-0%
|
|
2023 Q3
|
0.05%
|
32,710
|
$201.05
|
$6,576,346
|
+2.19% (+700)
|
+0%
|
|
2023 Q2
|
0.06%
|
32,010
|
$241.33
|
$7,724,973
|
-3.12% (-1,030)
|
-0%
|
|
2022 Q3
|
0.06%
|
$204.81
|
-2.28% (-770)
|
|||
|
2022 Q2
|
0.07%
|
$234.37
|
+8.12% (+2,540)
|
|||
|
2022 Q1
|
0.06%
|
$263.67
|
+23.11% (+5,870)
|
|||
|
2021 Q4
|
0.06%
|
$314.21
|
+3.72% (+910)
|
|||
|
2021 Q3
|
0.05%
|
$281.42
|
+21.42% (+4,320)
|
|||
|
2021 Q2
|
0.04%
|
$275.86
|
+6.10% (+1,160)
|
|||
|
2021 Q1
|
0.04%
|
$255.02
|
+11.76% (+2,000)
|
|||
|
2020 Q4
|
0.03%
|
$203.53
|
+53.38% (+5,920)
|
|||
|
2020 Q3
|
0.02%
|
$188.28
|
+11.79% (+1,170)
|
|||
|
2020 Q2
|
0.02%
|
$166.13
|
+18.38% (+1,540)
|
|||
|
2020 Q1
|
0.01%
|
$126.37
|
+1.21% (+100)
|
|||
|
2019 Q4
|
0.01%
|
$169.20
|
+13.74% (+1,000)
|
|||
|
2019 Q3
|
0.01%
|
$167.99
|
+39.73% (+2,070)
|
|||
|
2019 Q2
|
0.01%
|
$172.94
|
new
|
|||
|
2014 Q4
|
0.00%
|
$101.70
|
-100% (-4,710)
|
|||
|
2014 Q3
|
0.01%
|
$101.70
|
+1.29% (+60)
|
|||
|
2014 Q2
|
0.01%
|
$102.37
|
-18.28% (-1,040)
|
|||
|
2014 Q1
|
0.01%
|
$98.24
|
+20.30% (+960)
|
|||
|
2013 Q4
|
0.01%
|
$91.33
|
+3.28% (+150)
|
|||
|
2013 Q3
|
0.01%
|
$99.13
|
-99.67% (-1,390,864)
|
|||
|
2013 Q2
|
2.29%
|
$100.10
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.